BSE filing, NSE: VINRKLB. Summary written from the filing by ALFA Finder's alert engine.
Rekvina Laboratories Ltd: key numbers
- Share price
- ₹61.03
- Market cap
- ₹36.79 Cr
- Revenue (annual)
- ₹1.27 Cr
- Net profit (annual)
- ₹-0.25 Cr
- P/E (TTM)
- -108.3×Sector 43.0×
- Promoter holding
- 77.00%+35.70% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rekvina Laboratories Ltd
All →Rekvina Laboratories Board Meeting Date
Rekvina Laboratories has scheduled its Board meeting for November 13, 2026, to approve Q2 FY27 un-audited financial results. No material financial figures are disclosed at this stage.
Rekvina Laboratories Business Update
Subsidiary Radiant Parenterals will temporarily shut its manufacturing facility from October 28, 2026. The shutdown supports renovation and installation of an additional vial line.
Rekvina Laboratories Other Announcement
Rekvina Laboratories Limited submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Rekvina Laboratories Management Change
Rekvina Laboratories Limited has appointed Mr. Subrata Samanta as its new Chief Financial Officer and Key Managerial Personnel, effective October 7, 2026.
Rekvina Laboratories Annual General Meeting
Rekvina Laboratories Ltd held its 38th Annual General Meeting on September 29, 2026, approving financial statements and appointing directors.
Rekvina Laboratories Management Change
Rekvina Laboratories Ltd announced a change in its registered office within the city and the resignation of its Managing Director, Mr. Amit Shah.
Other board meeting date announcements
All →Roopa Industries Board Meeting Date
Roopa Industries Ltd intimated a board meeting on 14 Nov 2026 to consider unaudited half-year and quarterly results ended 30 Sep 2026. Trading window stays closed until 48 hours after results are made public.
Uravi Defence and Technology Board Meeting Date
Uravi Defence schedules a board meeting on 14 November 2026 to approve September quarter and half-year results. Trading window remains closed until 48 hours post-results.
Soma Textiles & Industries Board Meeting Date
Soma Textiles will hold a board meeting on 11 November 2026 to consider quarterly results for September 2026. The trading window remains closed until 13 November 2026.
Panorama Studios International Board Meeting Date
Panorama Studios scheduled a board meeting for 14 November 2026 to consider unaudited standalone and consolidated results. The agenda includes a limited review report and other business.
DCM Shriram Fine Chemicals Board Meeting Date
DCM Shriram Fine Chemicals scheduled a board meeting for 14 November 2026 to consider unaudited standalone and consolidated results. The results cover the quarter and half year ended September 30, 2026.
Kamanwala Housing Construction Board Meeting Date
Kamanwala Housing scheduled a board meeting for 14 November 2026 to consider unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.